Company / Revenue
Centessa Pharmaceuticals plc Revenue History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$15.0M
FY2025
5-year range
$0 / $15.0M
FY2022-FY2025
Trend
-
vs FY2024
Sector context
#133 of 155
Health Care
What the data says
Centessa Pharmaceuticals plc's revenue of $15M is lower than 86% of companies in the Health Care sector (FY2025). Improved from $7M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2025.
Improved from $7M to $15M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 155This company $15.0M Sector average $4.5B
▼
-99.7% below sector average
Key checks
Key Insights
- Ranks #133 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.0M | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $6.9M | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026